CTKB

CTKB

USD

Cytek Biosciences Inc. Common Stock

$3.440-0.080 (-2.273%)

Prix en Temps Réel

Healthcare
Dispositifs médicaux
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$3.520

Haut

$3.570

Bas

$3.415

Volume

1.30M

Fondamentaux de l'Entreprise

Capitalisation Boursière

435.7M

Industrie

Dispositifs médicaux

Pays

United States

Statistiques de Trading

Volume Moyen

1.07M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $2.37Actuel $3.440Haut $7.63

Actualités Connexes

GlobeNewswire

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th

Voir plus
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $7

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences with a Equal-Weight and lowers the price target from $9 to $7.

Voir plus
Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $7
GlobeNewswire

Cytek Biosciences Reports First Quarter 2025 Financial Results

FREMONT, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the first

Voir plus
Cytek Biosciences Reports First Quarter 2025 Financial Results

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.